Translational Projects
From Research to the Clinic
Translational Projects are aimed at interdisciplinary consortia of five to eight researchers whose groups work in the field of precision medicine. Projects must be designed so that the medical problem they address can only be solved successfully if all participating research groups – from basic biomedical research, biomedical informatics, engineering, and clinical research – work together. Early clinical studies are intended to demonstrate that the proposed solution is effective in patients.
For Translational Projects, it is essential that the proposed solutions are tested in a clinical research setting: over the course of the project, the consortium must demonstrate that the proposed therapeutic or diagnostic approach achieves the desired effect in patients (proof of concept). Translational Projects are intended to lay the foundation for potential subsequent clinical development.
In addition to their specific scientific results, the projects should also contribute to the further development of Zurich as a research hub. They make use of the existing infrastructure in information technology, biobanks, and clinical research at the University of Zurich, ETH Zurich, and the four participating university hospitals, and contribute to its further development.
The total budget for a Translational Project in precision medicine is up to CHF 5 million for a project duration of five years.
INTeRCePT
Reducing treatment resistance in blood cancer: optimizing treatment strategies by analyzing patient-specific tumor characteristics in children and adults
mTORUS
New treatment options for urinary tract infections by combining antibacterial therapy with microbiome substitution